Metabolic and carbohydrate characteristics of different phenotypes of polycystic ovary syndrome

dc.authoridTaskapan, Mehmet Cagatay/0000-0002-5273-4909
dc.authoridBerker, Bulent/0000-0001-7346-7128
dc.authoridAta, Baris/0000-0003-1106-3747
dc.authoridCelik, ebru/0000-0002-0774-4294
dc.authoridKaraer, Abdullah/0000-0002-2010-6211
dc.authoridStark, Michael/0000-0002-1481-9506
dc.authoridTURKCUOGLU, ILGIN/0000-0002-8342-1956
dc.authorwosidTaskapan, Mehmet Cagatay/ABI-7747-2020
dc.authorwosidBerker, Bulent/AAI-8861-2020
dc.authorwosidAta, Baris/C-8049-2013
dc.authorwosidCelik, ebru/X-4343-2019
dc.authorwosidKaraer, Abdullah/ABI-4667-2020
dc.contributor.authorCelik, Ebru
dc.contributor.authorTurkcuoglu, Ilgin
dc.contributor.authorAta, Baris
dc.contributor.authorKaraer, Abdullah
dc.contributor.authorKirici, Pinar
dc.contributor.authorEraslan, Sevil
dc.contributor.authorTaskapan, Cagatay
dc.date.accessioned2024-08-04T20:42:52Z
dc.date.available2024-08-04T20:42:52Z
dc.date.issued2016
dc.departmentİnönü Üniversitesien_US
dc.description.abstractObjective: To compare the prevalence of various metabolic and cardiovascular risk factors and insulin resistance between polycystic ovary syndrome (PCOS) patients with or without hyperandrogenism. Material and Methods: This is a retrospective cross-sectional study involving women with PCOS as diagnosed according to the Androgen Excess (AE) Society definition (n=504) and women with normoandrogenemic PCOS (n=183). Anthropometrics, lipid profile, glucose, insulin, oral glucose tolerance test (OGTT), and reproductive hormone levels were evaluated. Results: Women with PCOS diagnosed according to the AE Society had a significantly higher prevalence of metabolic syndrome compared with the normoandrogenemic PCOS phenotype: odds ratio (OR) 2.95 [95% confidence interval (CI) 1.21-7.21]. There was no significant difference in the prevalence glucose intolerance test between the groups [OR: 2.15, 95% CI 0.71-6.56]. The prevalence of low high density lipoprotein (HDL)-cholesterol in the group under the AE-PCOS Society criteria was higher than that of the normoandrogenemic PCOS group [OR: 2.82, 95% CI 1.29-3.36]. Conclusion: The risks of metabolic syndrome and cardiovascular disease may vary among the phenotypes of PCOS based on the Rotterdam criteria. This new data may be of reference in informing women with PCOS, although further prospective studies are needed to validate this proposition.en_US
dc.identifier.doi10.5152/jtgga.2016.16133
dc.identifier.endpage208en_US
dc.identifier.issn1309-0399
dc.identifier.issn1309-0380
dc.identifier.issue4en_US
dc.identifier.pmid27990089en_US
dc.identifier.scopus2-s2.0-85006272248en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage201en_US
dc.identifier.urihttps://doi.org/10.5152/jtgga.2016.16133
dc.identifier.urihttps://hdl.handle.net/11616/97634
dc.identifier.volume17en_US
dc.identifier.wosWOS:000391065300006en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.ispartofJournal of The Turkish-German Gynecological Associationen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPolycystic ovary syndromeen_US
dc.subjectdiagnostic categoriesen_US
dc.subjectmetabolic syndromeen_US
dc.subjecthyperanderogenismen_US
dc.subjectinsulin resistanceen_US
dc.titleMetabolic and carbohydrate characteristics of different phenotypes of polycystic ovary syndromeen_US
dc.typeArticleen_US

Dosyalar